BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-0131-2024

Cardinal Health Inc. · Dublin, OH

Class I — life-threatening Ongoing 926 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death. Distribution is nationwide and the recall remains in progress.

Product

LEADER brand Eye Irritation Relief (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline Hydrochloride 0.05%), 0.5 FL OZ (15 mL) dropper bottles, Sterile, Distributed By Cardinal Health, Dublin, Ohio 43017, Made in India NDC: 70000-0087-1

Lot / code: ALL LOTS

Quantity: 11629 units

Reason for recall

Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Recall record

Recall number
D-0131-2024
Classification
Class I
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Press Release
Distribution
Nationwide in the USA
Recall initiated
2023-10-31
Classified by FDA Center
2023-12-01
FDA published
2023-11-29
Recalling firm
Cardinal Health Inc.
Firm location
Dublin, OH

Drug identification

Brand name(s)
EYES IRRITATION RELIEF
Generic name(s)
POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE
Manufacturer(s)
CARDINAL HEALTH 110, LLC. DBA LEADER
NDC(s)
70000-0087
Route(s)
OPHTHALMIC

Operational response

A Class I recall indicates a strong likelihood of serious adverse health consequence or death. Pull affected lots from active dispensing immediately. Segregate inventory in a marked, locked location pending destruction or return. If product has already been dispensed, identify affected patients and contact them by your standard recall-notification protocol.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls